SANITAS STOCK EXCHANGE RELEASE 18.01.2007. On the Renewal of the Sale of „Corhydron“ On the basis of the decision of January 17, 2007 made by Polish General Pharmaceutical Inspection, the sale of „Corhydron“ 100 and „Corhydron“ 25 – medicine, manufactured by Jelfa was renewed. This decision was made after pharmaceutical inspectors had investigated all documentation and records of manufacturing and packing of the said product, the procedures of cleaning of manufacturing premises and production lines, took into account their efficiency. The investigation proved the fact that there was no possibility of contaminating „Corhydron” with other substances in the process of its manufacturing. The sale of „Corchydron“ 250 was renewed earlier on. Head of Legal and general issues department Ruta Milkuviene +370 37 20 06 62